These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35271946)

  • 21. Natural Products Are a Promising Source for Anthelmintic Drug Discovery.
    Jayawardene KLTD; Palombo EA; Boag PR
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Throughput Screening of the NatureBank 'Marine Collection' in a
    Taki AC; Byrne JJ; Jabbar A; Lum KY; Hayes S; Addison RS; Ramage KS; Hofmann A; Ekins MG; Wang T; Chang BCH; Davis RA; Gasser RB
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics.
    Abriola L; Hoyer D; Caffrey CR; Williams DL; Yoshino TP; Vermeire JJ
    PLoS One; 2019; 14(6):e0217019. PubMed ID: 31158236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.
    Kaewintajuk K; Cho PY; Kim SY; Lee ES; Lee HK; Choi EB; Park H
    Parasitol Res; 2010 Jun; 107(1):27-30. PubMed ID: 20309581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic screening of the 'Kurz-box' of chemicals identifies two compounds (BLK127 and HBK4) with anthelmintic activity in vitro against parasitic larval stages of Haemonchus contortus.
    Nguyen LT; Kurz T; Preston S; Brueckmann H; Lungerich B; Herath HMPD; Koehler AV; Wang T; Skálová L; Jabbar A; Gasser RB
    Parasit Vectors; 2019 Apr; 12(1):191. PubMed ID: 31039802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing anthelmintic resistance--parasite fitness, drug use strategy and the potential for reversion towards susceptibility.
    Leathwick DM
    Vet Parasitol; 2013 Nov; 198(1-2):145-53. PubMed ID: 24074608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caenorhabditis elegans muscle Cys-loop receptors as novel targets of terpenoids with potential anthelmintic activity.
    Hernando G; Turani O; Bouzat C
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007895. PubMed ID: 31765374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Working towards New Drugs against Parasitic Worms in a Public-Development Partnership.
    Preston S; Gasser RB
    Trends Parasitol; 2018 Jan; 34(1):4-6. PubMed ID: 28784352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal worm egg count analysis for targeting anthelmintic treatment in horses: points to consider.
    Lester HE; Matthews JB
    Equine Vet J; 2014 Mar; 46(2):139-45. PubMed ID: 24131301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.
    Abdulla MH; Ruelas DS; Wolff B; Snedecor J; Lim KC; Xu F; Renslo AR; Williams J; McKerrow JH; Caffrey CR
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e478. PubMed ID: 19597541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A perspective on genomic-guided anthelmintic discovery and repurposing using Haemonchus contortus.
    Preston S; Jabbar A; Gasser RB
    Infect Genet Evol; 2016 Jun; 40():368-373. PubMed ID: 26144657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-content approaches to anthelmintic drug screening.
    Zamanian M; Chan JD
    Trends Parasitol; 2021 Sep; 37(9):780-789. PubMed ID: 34092518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of anthelmintic resistance with best practice control of nematodes on commercial sheep farms in the UK.
    Learmount J; Stephens N; Boughtflower V; Barrecheguren A; Rickell K
    Vet Parasitol; 2016 Oct; 229():9-14. PubMed ID: 27809985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthelmintic metabolism in parasitic helminths: proteomic insights.
    Brophy PM; MacKintosh N; Morphew RM
    Parasitology; 2012 Aug; 139(9):1205-17. PubMed ID: 22776506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthelmintic resistance.
    Craig TM
    Vet Parasitol; 1993 Feb; 46(1-4):121-31. PubMed ID: 8484205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the Biological Application of Fluorescent Benzothiadiazole Derivatives: A Phenotypic Screening Strategy for Anthelmintic Drug Discovery Using
    Cintra GAS; Neto BAD; Carvalho PHPR; Moraes CB; Freitas-Junior LH
    SLAS Discov; 2019 Aug; 24(7):755-765. PubMed ID: 31180789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing anthelmintic resistance: is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class?
    Leathwick DM; Hosking BC; Bisset SA; McKay CH
    N Z Vet J; 2009 Aug; 57(4):181-92. PubMed ID: 19649011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthelmintics: From discovery to resistance II (San Diego, 2016).
    Martin RJ; Wolstenholme AJ; Caffrey CR
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):297-298. PubMed ID: 27814986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthelmintic resistance in cattle nematodes in the US.
    Gasbarre LC
    Vet Parasitol; 2014 Jul; 204(1-2):3-11. PubMed ID: 24798800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming drug resistance for macro parasites.
    Srivastava M; Misra-Bhattacharya S
    Future Microbiol; 2015; 10(11):1783-9. PubMed ID: 26517758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.